Cargando…
Immune adjuvant therapy using Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments
The cell wall skeleton of Bacillus Calmette–Guérin (BCG-CWS) is a bioactive component that is a strong immune adjuvant for cancer immunotherapy. BCG-CWS activates the innate immune system through various pattern recognition receptors and is expected to elicit antigen-specific cellular immune respons...
Autores principales: | Nishida, Sumiyuki, Tsuboi, Akihiro, Tanemura, Atsushi, Ito, Toshinori, Nakajima, Hiroko, Shirakata, Toshiaki, Morimoto, Soyoko, Fujiki, Fumihiro, Hosen, Naoki, Oji, Yusuke, Kumanogoh, Atsushi, Kawase, Ichiro, Oka, Yoshihiro, Azuma, Ichiro, Morita, Satoshi, Sugiyama, Haruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831317/ https://www.ncbi.nlm.nih.gov/pubmed/31415377 http://dx.doi.org/10.1097/MD.0000000000016771 |
Ejemplares similares
-
Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CT
por: Nakata, Jun, et al.
Publicado: (2020) -
A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer
por: Shibata, Takeo, et al.
Publicado: (2022) -
WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers
por: Oka, Yoshihiro, et al.
Publicado: (2007) -
An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells
por: Hasegawa, Kana, et al.
Publicado: (2015) -
Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine
por: Takashima, Satoshi, et al.
Publicado: (2016)